Earnings Call Intelligence Subscribe
Home › Call Sheets › OXY › Q4'25
Call sheet · Q4'25

Occidental Petroleum (OXY)

Q4'25 earnings call · held February 19, 2026 · compared with the Q3'25 call · management-credibility review
10/12
Disclosure score
6 low flags
Financial quality
Bottom line
The sleeper story is operational excellence at scale - they delivered record production while cutting total spending by $575M, with structural cost savings accelerating to $500M in 2026. The obvious headline is successful OxyChem execution, but the real value is the $2B in cumulative efficiency gains since 2023 that stick regardless of oil prices. The binding constraint is capital discipline in an oversupplied market - Vicki explicitly said 'we're not going to aggressively put lots of extra barrels into an oversupplied market,' showing mature capital allocation. Most revealing quote: 'Our teams delivered record annual production while reducing total spending by $575 million' - this is industrial efficiency, not just oil price leverage. My view changes if they break discipline and chase that $400M growth capital at current oil prices, or if the midstream optimization cliff in 2026 is steeper than the $172M Q4 beat suggests.

The 30-second version

  • The sleeper story: Operational efficiency is carrying them at these oil prices
  • OxyChem sale execution was flawless, but now comes the hard part
  • Midstream beat by $500M+ but they're warning this rolls off in 2026

What changed this quarter

MetricQ3'25Q4'25Change
Total Production1.47M BOE/d (Q3)1.434M BOE/d (Q4)Slight sequential decline but beat full-year guidance high-end
Free Cash Flow (ex-WC)$1.5B (Q3)$1.0B (Q4)$500M sequential decline on lower oil prices
Adjusted EPS$0.65 (Q3)$0.31 (Q4)52% sequential drop, oil price reality
Domestic LOE per BOE$8.11 (Q3)$7.77 (Q4)New quarterly low since 2021, structural improvement
Midstream Pretax Income$153M (Q3)$172M above guidance (Q4)Beat by $172M on gas optimization
Principal Debt$20.8B (Q3)$15B (Q4, target $14.3B)$5.8B reduction, OxyChem execution
Capital Spending$1.7B (Q3)2026 guide $5.5-5.9B$550M reduction vs 2025 ex-OxyChem
Reserves ReplacementNot disclosed (Q3)107% organic, 98% all-inAbove 100% replacement maintained
Total Resource Base16.5B BOE (Q3)16.5B BOE (Q4)Stable at 30+ year runway
Quarterly DividendNot announced (Q3)8% increase announcedFirst meaningful hike in years

Accountability tracked

7 new promises made4 narrative shifts flagged6 prior promises scored
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Read the full OXY Q4'25 report Subscribe
About Research ↗Call SheetsCredibility IndexMissed PromisesScreens13F BooksData & InstitutionalPrivacyTermsSubscribe
This is a free preview. The full write-up and promise ledger are published to subscribers on Substack.
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.

Follow what management promises next

Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.

Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.